目录
- Efficacy and safety of anti-hepatic fibrosis drugs
- Focus on gastroesophageal reflux disease in patients with cystic fibrosis
- Origin and genomic characteristics of SARS-CoV-2 and its interaction with angiotensin converting enzyme type 2 receptors, focusing on the gastrointestinal tract
- Dihydromyricetin ameliorates chronic liver injury by reducing pyroptosis
- P-selectin glycoprotein ligand 1 deficiency prevents development of acute pancreatitis by attenuating leukocyte infiltration
- Associations of content and gene polymorphism of macrophage inhibitory factor-1 and chronic hepatitis C virus infection
- Escalating complexity of endoscopic retrograde cholangiopancreatography over the last decade with increasing reliance on advanced cannulation techniques
- Older age, longer procedures and tandem endoscopic-ultrasound as risk factors for post-endoscopic retrograde cholangiopancreatography bacteremia
- Signature based on molecular subtypes of deoxyribonucleic acid methylation predicts overall survival in gastric cancer
- Endoscopic gastric fenestration of debriding pancreatic walled-off necrosis: A pilot study
- Ischemic colitis after enema administration: Incidence, timing, and clinical features
- Real-world cost-effectiveness associated with infliximab maintenance therapy for moderate to severe Crohn’s disease in China
- Third-look endoscopy prevents delayed bleeding after endoscopic submucosal dissection under antithrombotic therapy
- Efficacy and safety of non-pharmacological interventions for irritable bowel syndrome in adults
- Comment on “Updated meta-analysis of pancreatic stent placement in preventing post-endoscopic retrograde cholangiopancreatography pancreatitis”